VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP 4
4 · Anthera Pharmaceuticals Inc · Filed Oct 4, 2010
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (right to buy)
2010-09-30+12,000→ 12,000 total(indirect: By: Annette Bianchi)Exercise: $4.19Exp: 2020-09-30→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable in equal monthly installments over a one-year period from July 9, 2010.
- [F2]VantagePoint Venture Associates IV, LLC has the sole power to exercise the option, and sole voting and investment power with respect to the shares underlying the option. Ms. Bianchi disclaims beneficial ownership thereof except to the extent of her pecuniary interest therein.